Identification of pathologically favorable disease in intermediate‐risk prostate cancer patients: Implications for active surveillance candidates selection

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0045|75|13|1484-1491

ISSN： 0270-4137

Source： THE PROSTATE, Vol.75, Iss.13, 2015-09, pp. : 1484-1491

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Androgen deprivation therapy and the risk of death from prostate cancer among men with favorable or unfavorable intermediate‐risk disease

By  

CANCER, Vol. 121, Iss. 16, 2015-08 ,pp. : 2713-2719

John Wiley & Sons Inc

Access to resources Recommend Favorite

Stratification of patients with intermediate‐risk prostate cancer

By  

BJU INTERNATIONAL, Vol. 115, Iss. 6, 2015-06 ,pp. : 907-912

John Wiley & Sons Inc

Access to resources Recommend Favorite

Importance of prostate volume in the stratification of patients with intermediate‐risk prostate cancer

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 6, 2015-06 ,pp. : 555-561

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial Comment to Importance of prostate volume in the stratification of patients with intermediate‐risk prostate cancer

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 6, 2015-06 ,pp. : 561-562

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is There a Role for Active Surveillance in Low-Risk Prostate Cancer?

By  

Urologia Internationalis, Vol. 95, Iss. 2, 2015-03 ,pp. : 125-131

Karger

Access to resources Recommend Favorite